Multi-Center, Randomized, Double-blinding, Positive-control, 24-Week Trial of the Efficacy and Safety of Clevudine Capsules Compared with Adefovir Dipivoxil Tablets in HBeAg Positive and Negative Chronic Hepatitis B Patients.

Trial Profile

Multi-Center, Randomized, Double-blinding, Positive-control, 24-Week Trial of the Efficacy and Safety of Clevudine Capsules Compared with Adefovir Dipivoxil Tablets in HBeAg Positive and Negative Chronic Hepatitis B Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Adefovir dipivoxil (Primary) ; Clevudine (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Actual end date changed from 1 Jun 2010 to 31 Dec 2010 as reported by Chinese Clinical Trial Register.
    • 27 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top